| Year |
Title |
Altmetric |
| 2022
|
Reproxalap Activity and Estimation of Clinically Relevant Thresholds for Ocular Itching and Redness in a Randomized Allergic Conjunctivitis Field Trial.
Ophthalmology and Therapy.
11:1449-1461.
2022
|
|
| 2022
|
Nicotinic acetylcholine receptor stimulation: A new approach for stimulating tear secretion in dry eye disease.
The Ocular Surface.
25:58-64.
2022
|
|
| 2022
|
Topical Review: An Update of Diagnostic and Management Algorithms for Acquired Blepharoptosis.
Optometry and Vision Science.
99:230-240.
2022
|
|
| 2022
|
Classification of Presbyopia by Severity.
Ophthalmology and Therapy.
11.
2022
|
|
| 2022
|
Correction to: Classification of Presbyopia by Severity (Ophthalmology and Therapy, (2022), 11, 1, (1-11), 10.1007/s40123-021-00410-w).
Ophthalmology and Therapy.
11:13-14.
2022
|
|
| 2022
|
Human meibum and tear film derived cholesteryl and wax esters in meibomian gland dysfunction and tear film structure: Cholesteryl and wax esters in meibomian gland dysfunction.
The Ocular Surface.
23:12-23.
2022
|
|
| 2022
|
Prostaglandin E<sub>2</sub> and F<sub>2α</sub> alter expression of select cholesteryl esters and triacylglycerols produced by human meibomian gland epithelial cells.
Cornea.
41:95-105.
2022
|
|
| 2022
|
Reduction of Artificial Tears and Use of Adjunctive Dry Eye Therapies After Lifitegrast Treatment: Evidence from Clinical and Real-World Studies.
Clinical Ophthalmology.
16:909-916.
2022
|
|
| 2021
|
Tear Film Surface Quality in Modern Daily Disposable Contact Lens Wear.
Eye and Contact Lens: science and clinical practice.
47:631-637.
2021
|
|
| 2021
|
Corrigendum to “Human precorneal tear film and lipid layer dynamics in meibomian gland dysfunction” [Ocul Surf 21 (2021) 250–256] (The Ocular Surface (2021) 21 (250–256), (S1542012421000185), (10.1016/j.jtos.2021.03.006)).
The Ocular Surface.
22:133-134.
2021
|
|
| 2021
|
Human meibum and tear film derived (O-Acyl)-omega-hydroxy fatty acids as biomarkers of tear film dynamics in meibomian gland dysfunction and dry eye disease.
Investigative Ophthalmology and Visual Science.
62.
2021
|
|
| 2021
|
Human meibum and tear film derived (O-acyl)-omega-hydroxy fatty acids in meibomian gland dysfunction.
The Ocular Surface.
21:118-128.
2021
|
|
| 2021
|
Human precorneal tear film and lipid layer dynamics in meibomian gland dysfunction.
The Ocular Surface.
21:250-256.
2021
|
|
| 2021
|
Triacylglycerol lipidome from human meibomian gland epithelial cells: Description, response to culture conditions, and perspective on function.
Experimental Eye Research.
207.
2021
|
|
| 2021
|
Safety of KPI-121 Ophthalmic Suspension 0.25% in Patients With Dry Eye Disease: A Pooled Analysis of 4 Multicenter, Randomized, Vehicle-Controlled Studies.
Cornea.
40:564-570.
2021
|
|
| 2021
|
Saturation of cholesteryl esters produced by human meibomian gland epithelial cells after treatment with rosiglitazone.
The Ocular Surface.
20:39-47.
2021
|
|
| 2021
|
A Comprehensive Review of the Clinical Trials Conducted for Dry Eye Disease and the Impact of the Vehicle Comparators in These Trials.
Current Eye Research.
46:609-614.
2021
|
|
| 2021
|
Real-world experience with lifitegrast ophthalmic solution (Xiidra®) in the us and canada: Retrospective study of patient characteristics, treatment patterns, and clinical effectiveness in 600 patients with dry eye disease.
Clinical Ophthalmology.
15:1041-1054.
2021
|
|
| 2020
|
The closed eye harbours a unique microbiome in dry eye disease.
Scientific Reports.
10.
2020
|
|
| 2020
|
Enhanced closed eye neutrophil degranulation in dry eye disease.
The Ocular Surface.
18:841-851.
2020
|
|
| 2020
|
Evaluation of cell harvesting techniques to optimize lipidomic analysis from human meibomian gland epithelial cells in culture.
International Journal of Molecular Sciences.
21.
2020
|
|
| 2020
|
Dry Eye Disease Practice in Ghana: Diagnostic Perspectives, Treatment Modalities, and Challenges.
Optometry and Vision Science.
97:137-144.
2020
|
|
| 2020
|
The closed eye harbors a unique microbiome in dry eye disease
2020
|
|
| 2019
|
Effect of the Bruder moist heat eye compress on contact lens discomfort in contact lens wearers: An open-label randomized clinical trial.
Contact Lens and Anterior Eye.
42:625-632.
2019
|
|
| 2019
|
Tear Film and Meibomian Gland Characteristics in Adolescents.
Cornea.
38:1475-1482.
2019
|
|
| 2019
|
Efficacy of topical ophthalmic drugs in the treatment of dry eye disease: A systematic literature review.
The Ocular Surface.
17:412-423.
2019
|
|
| 2019
|
Safety and tolerability of lifitegrast ophthalmic solution 5.0%: Pooled analysis of five randomized controlled trials in dry eye disease.
European Journal of Ophthalmology.
29:394-401.
2019
|
|
| 2019
|
Dry eye disease: Consideration for women's health.
Journal of Women's Health.
28:502-514.
2019
|
|
| 2019
|
Untargeted lipidomic analysis of human tears: A new approach for quantification of O-acyl-omega hydroxy fatty acids.
The Ocular Surface.
17:347-355.
2019
|
|
| 2019
|
Erratum: Comprehensive shotgun lipidomics of human meibomian gland secretions using MS/MSall with successive switching between acquisition polarity modes (Journal of Lipid Research (2018) 59 (2223-2236) DOI: 10.1194/jlr.D088138).
Journal of Lipid Research.
60:1640.
2019
|
|
| 2018
|
Comparison of Collection Methods for the Measure of Human Meibum and Tear Film-Derived Lipids Using Mass Spectrometry.
Current Eye Research.
43:1244-1252.
2018
|
|
| 2018
|
Leukocyte Distribution in the Open Eye Tears of Normal and Dry Eye Subjects.
Current Eye Research.
43:1253-1259.
2018
|
|
| 2018
|
Short Tandem Repeat (STR) Profiles of Commonly Used Human Ocular Surface Cell Lines.
Current Eye Research.
43:1097-1101.
2018
|
|
| 2018
|
Relation Between Dietary Essential Fatty Acid Intake and Dry Eye Disease and Meibomian Gland Dysfunction in Postmenopausal Women.
American Journal of Ophthalmology.
189:29-40.
2018
|
|
| 2018
|
Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a phase III randomized controlled trial.
Clinical Ophthalmology.
12:263-270.
2018
|
|
| 2018
|
Asingle vectored thermal pulsation treatment for meibomian gland dysfunction increases mean comfortable contact lens wearing time by approximately 4 hours per day.
Clinical Ophthalmology.
12:169-183.
2018
|
|
| 2018
|
Comprehensive shotgun lipidomics of human meibomian gland secretions using MS/MSall with successive switching between acquisition polarity modes.
Journal of Lipid Research.
59:2223-2236.
2018
|
|
| 2018
|
Erratum: Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial [Corrigendum]..
Clinical Ophthalmology.
12:913.
2018
|
|
| 2017
|
Neutrophil and T-cell homeostasis in the closed eye.
Investigative Ophthalmology and Visual Science.
58:6212-6220.
2017
|
|
| 2017
|
TFOS DEWS II Report Executive Summary.
The Ocular Surface.
15:802-812.
2017
|
|
| 2017
|
TFOS DEWS II Definition and Classification Report.
The Ocular Surface.
15:276-283.
2017
|
|
| 2017
|
TFOS DEWS II Introduction.
The Ocular Surface.
15:269-275.
2017
|
|
| 2017
|
Expression profiling of nonpolar lipids in meibum from patients with dry eye: A pilot study.
Investigative Ophthalmology and Visual Science.
58:2266-2274.
2017
|
|
| 2017
|
Lifitegrast for the Treatment of Dry Eye Disease: Results of a Phase III, Randomized, Double-Masked, Placebo-Controlled Trial (OPUS-3).
Ophthalmology.
124:53-60.
2017
|
|
| 2016
|
Compositional Analysis of Wax Esters in Human Meibomian Gland Secretions by Direct Infusion Electrospray Ionization Mass Spectrometry.
Lipids.
51:1269-1287.
2016
|
|
| 2016
|
A randomized, double-masked, parallel-group, comparative study to evaluate the clinical efficacy and safety of 1% azithromycin–0.1% dexamethasone combination compared to 1% azithromycin alone, 0.1% dexamethasone alone, and vehicle in the treatment of subjects with blepharitis.
Clinical Ophthalmology.
10:1495-1503.
2016
|
|
| 2016
|
Functional and morphologic changes of meibomian glands in an asymptomatic adult population.
Investigative Ophthalmology and Visual Science.
57:3996-4007.
2016
|
|
| 2016
|
Impact of dry eye disease on work productivity, and patients’ Satisfaction with Over-The-Counter dry eye treatments.
Investigative Ophthalmology and Visual Science.
57:2975-2982.
2016
|
|
| 2016
|
Report of the Inaugural Meeting of the TFOS i2 = initiating innovation Series: Targeting the Unmet Need for Dry Eye Treatment.
The Ocular Surface.
14:264-316.
2016
|
|
| 2016
|
Analysis of tear inflammatory mediators: A comparison between the microarray and luminex methods.
Molecular Vision.
22:177-188.
2016
|
|
| 2016
|
Association between serum levels of testosterone and estradiol with meibomian gland assessments in postmenopausal women.
Investigative Ophthalmology and Visual Science.
57:295-300.
2016
|
|
| 2016
|
Differential profiling of T-cell cytokines as measured by protein microarray across dry eye subgroups.
Cornea.
35:329-335.
2016
|
|
| 2016
|
Safety of lifitegrast ophthalmic solution 5.0% in patients with dry eye disease: A 1-year, multicenter, randomized, placebo-controlled study.
Cornea.
35:741-748.
2016
|
|
| 2015
|
Agreement between automated and traditional measures of tear film breakup.
Optometry and Vision Science.
92:e257-e263.
2015
|
|
| 2015
|
Dry eye disease.
Optometry and Vision Science.
92:922-924.
2015
|
|
| 2015
|
Characterization of Wax Esters by Electrospray Ionization Tandem Mass Spectrometry: Double Bond Effect and Unusual Product Ions.
Lipids.
50:821-836.
2015
|
|
| 2015
|
Clinical guidelines for management of dry eye associated with Sjögren disease.
The Ocular Surface.
13:118-132.
2015
|
|
| 2014
|
Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: Clinical implications.
Acta Ophthalmologica.
92:161-166.
2014
|
|
| 2014
|
Erratum: Erratum to: Rethinking dry eye disease: A perspective on clinical implications (Ocul Surf (2014) 12:2S (S1-S32)).
The Ocular Surface.
12:231.
2014
|
|
| 2014
|
Rethinking dry eye disease: A perspective on clinical implications.
The Ocular Surface.
12.
2014
|
|
| 2013
|
The TFOS International Workshop on Contact Lens Discomfort: Executive summary.
Investigative Ophthalmology and Visual Science.
54.
2013
|
|
| 2013
|
The TFOS International Workshop on Contact Lens Discomfort: Report of the definition and classification subcommittee.
Investigative Ophthalmology and Visual Science.
54.
2013
|
|
| 2013
|
Quantitative profiling of major neutral lipid classes in human meibum by direct infusion electrospray ionization mass spectrometry.
Investigative Ophthalmology and Visual Science.
54:5730-5753.
2013
|
|
| 2013
|
Tear film breakup and structure studied by simultaneous video recording of fluorescence and tear film lipid layer images.
Investigative Ophthalmology and Visual Science.
54:4900-4909.
2013
|
|
| 2013
|
An algorithm for the management of allergic conjunctivitis.
Allergy and Asthma Proceedings.
35:408-420.
2013
|
|
| 2013
|
Dry eye disease and microbial keratitis: Is there a connection?.
The Ocular Surface.
11:75-92.
2013
|
|
| 2012
|
Improving awareness, identification, and management of meibomian gland dysfunction.
Ophthalmology.
119.
2012
|
|
| 2012
|
The use of fluorescent quenching in studying the contribution of evaporation to tear thinning.
Investigative Ophthalmology and Visual Science.
53:5426-5432.
2012
|
|
| 2012
|
Tofacitinib (CP-690,550), a Janus kinase inhibitor for dry eye disease: Results from a phase 1/2 trial.
Ophthalmology.
119:1328-1335.
2012
|
|
| 2012
|
iTRAQ quantitative proteomics in the analysis of tears in dry eye patients.
Investigative Ophthalmology and Visual Science.
53:5052-5059.
2012
|
|
| 2012
|
Development of the 4-3-2-1 meibum expressibility scale.
Eye and Contact Lens: science and clinical practice.
38:86-92.
2012
|
|
| 2012
|
Quantification of genes and gene transcripts for microbial perchlorate reduction in fixed-bed bioreactors.
Journal of Applied Microbiology.
112:579-592.
2012
|
|
| 2012
|
Safety and efficacy of topical azithromycin ophthalmic solution 1.0% in the treatment of contact lens-related dry eye.
Eye and Contact Lens: science and clinical practice.
38:73-79.
2012
|
|
| 2012
|
Inter-examiner reliability in meibomian gland dysfunction assessment..
Investigative Ophthalmology and Visual Science.
53:3120-3125.
2012
|
|
| 2011
|
Rasch analysis of the Ocular Surface Disease Index (OSDI).
Investigative Ophthalmology and Visual Science.
52:8630-8635.
2011
|
|
| 2011
|
Examination of human meibum collection and extraction techniques.
Optometry and Vision Science.
88:525-533.
2011
|
|
| 2011
|
Author response: On the presence of (O-acyl)-omega-hydroxy fatty acids and their esters in human meibomian gland secretions.
Investigative Ophthalmology and Visual Science.
52:1894-1895.
2011
|
|
| 2011
|
The international workshop on meibomian gland dysfunction: Executive summary.
Investigative Ophthalmology and Visual Science.
52:1922-1929.
2011
|
|
| 2011
|
The international workshop on meibomian gland dysfunction: Introduction.
Investigative Ophthalmology and Visual Science.
52:1917-1921.
2011
|
|
| 2011
|
The international workshop on meibomian gland dysfunction: Report of the clinical trials subcommittee.
Investigative Ophthalmology and Visual Science.
52:2065-2085.
2011
|
|
| 2011
|
The international workshop on meibomian gland dysfunction: Report of the subcommittee on management and treatment of meibomian gland dysfunction.
Investigative Ophthalmology and Visual Science.
52:2050-2064.
2011
|
|
| 2011
|
The international workshop on meibomian gland dysfunction: Report of the subcommittee on the epidemiology of, and associated risk factors for, MGD.
Investigative Ophthalmology and Visual Science.
52:1994-2005.
2011
|
|
| 2011
|
High resolution microscopy of the lipid layer of the tear film.
The Ocular Surface.
9:197-211.
2011
|
|
| 2010
|
An objective approach to dry eye disease severity.
Investigative Ophthalmology and Visual Science.
51:6125-6130.
2010
|
|
| 2010
|
Re-on the presence and role of polar lipids in meibum.
Investigative Ophthalmology and Visual Science.
51:6910-6911.
2010
|
|
| 2010
|
Shotgun lipidomic analysis of human meibomian gland secretions with electrospray ionization tandem mass spectrometry.
Investigative Ophthalmology and Visual Science.
51:6220-6231.
2010
|
|
| 2010
|
Evaluation of extractants and precipitants in tear film proteomic analyses.
Optometry and Vision Science.
87:854-860.
2010
|
|
| 2010
|
Gas permeable and soft contact lens wear in children.
Optometry and Vision Science.
87:414-420.
2010
|
|
| 2009
|
The contribution of lipid layer movement to tear film thinning and breakup.
Investigative Ophthalmology and Visual Science.
50:2747-2756.
2009
|
|
| 2009
|
Blepharitis in the United States 2009: A Survey-based Perspective on Prevalence and Treatment.
The Ocular Surface.
7:s1-s14.
2009
|
|
| 2009
|
Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment..
The Ocular Surface.
7:S1-S14.
2009
|
|
| 2009
|
Blepharitis in the United States 2009: A survey-based perspective on prevalence and treatment.
The Ocular Surface.
7:S1.
2009
|
|
| 2009
|
Editorial: Collecting tear osmolarity measurements in the diagnosis of dry eye.
Expert Review of Ophthalmology.
4:451-453.
2009
|
|
| 2009
|
Epinastine 0.05% ophthalmic solution in contact lens-wearing subjects with a history of allergic conjunctivitis.
Eye and Contact Lens: science and clinical practice.
35:26-31.
2009
|
|
| 2008
|
Contributions of evaporation and other mechanisms to tear film thinning and break-up.
Optometry and Vision Science.
85:623-630.
2008
|
|
| 2008
|
The changing times in dry eye research.
Optometry and Vision Science.
85:613-614.
2008
|
|
| 2008
|
Investigation of the human tear film proteome using multiple proteomic approaches.
Molecular Vision.
14:456-470.
2008
|
|
| 2008
|
Current patterns in the use of diagnostic tests in dry eye evaluation.
Cornea.
27:656-662.
2008
|
|
| 2007
|
Diabetic eye examination report.
Optometry: Journal of the American Optometric Association.
78:588-595.
2007
|
|
| 2007
|
Identification of fatty acids and fatty acid amides in human meibomian gland secretions.
Investigative Ophthalmology and Visual Science.
48:34-39.
2007
|
|
| 2007
|
The contact lens and tear film laboratory, The Ohio State University College of Optometry.
The Ocular Surface.
5:259-261.
2007
|
|
| 2006
|
The global sex disparity in blindness and visual impairment.
Optometry and Vision Science.
83:700-701.
2006
|
|
| 2006
|
Sustained reductions in neonatal nosocomial infection rates following a comprehensive infection control intervention.
Journal of Perinatology.
26:176-179.
2006
|
|
| 2006
|
Interferometric imaging of the full thickness of the precorneal tear film.
Journal of the Optical Society of America A: Optics, Image Science and Vision.
23:2097-2104.
2006
|
|
| 2006
|
Patient-reported symptoms in dry dye disease.
The Ocular Surface.
4:137-145.
2006
|
|
| 2005
|
The frequency of dilated diabetic eye examinations by optometrists in the state of Ohio.
Optometry and Vision Science.
82:959-963.
2005
|
|
| 2005
|
Double-masked, placebo-controlled safety and efficacy trial of diguafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye (vol 23, pg 784, 2004).
Cornea.
24:637-637.
2005
|
|
| 2005
|
Self-reported dry eye disease across refractive modalities.
Investigative Ophthalmology and Visual Science.
46:1911-1914.
2005
|
|
| 2005
|
An assessment of grading scales for meibography images.
Cornea.
24:382-388.
2005
|
|
| 2005
|
Assessment of meibomian lipids in postmenopausal women using electrospray ionization mass spectrometry.
Investigative Ophthalmology and Visual Science.
46.
2005
|
|
| 2005
|
Human tear film breakup studied by a new imaging interferometer: Preliminary observations.
Investigative Ophthalmology and Visual Science.
46.
2005
|
|
| 2005
|
Identification and analysis of polar and non-polar lipids from meibomian gland secretions using electrospray ionization mass spectrometry.
Investigative Ophthalmology and Visual Science.
46.
2005
|
|
| 2004
|
Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry-eye.
Cornea.
23:784-792.
2004
|
|
| 2004
|
Patients' perspectives on noncompliance with Diabetic Retinopathy Standard of Care Guidelines.
Optometry: Journal of the American Optometric Association.
75:709-716.
2004
|
|
| 2004
|
The lack of association between signs and symptoms in patients with dry eye disease.
Cornea.
23:762-770.
2004
|
|
| 2004
|
An assessment of self-reported disease classification in epidemiological studies of dry eye.
Investigative Ophthalmology and Visual Science.
45:3453-3457.
2004
|
|
| 2004
|
The Reliability and Validity of McMonnies Dry Eye Index.
Cornea.
23:365-371.
2004
|
|
| 2004
|
Assessment of the reliability of self-reported dry eye in contact lens wearers: The contact lens dry eye questionnaire (CLDEQ) short-form.
Investigative Ophthalmology and Visual Science.
45:U142-U142.
2004
|
|
| 2004
|
The Repeatability of Clinical Measurements of Dry Eye.
Cornea.
23:272-285.
2004
|
|
| 2004
|
Diquafosol tetrasodium: A novel dry eye therapy.
Expert Opinion on Investigational Drugs.
13:47-54.
2004
|
|
| 2004
|
Diquafosol tetrasodium: a novel dry eye therapy.
Expert Opinion on Investigational Drugs.
13:47-54.
2004
|
|
| 2003
|
The relation between tear film tests in patients with dry eye disease.
Ophthalmic and Physiological Optics.
23:553-560.
2003
|
|
| 2003
|
Adherence to diabetic standard of care guidelines.
Investigative Ophthalmology and Visual Science.
44:U113-U113.
2003
|
|
| 2003
|
Double masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye.
Investigative Ophthalmology and Visual Science.
44:U312-U312.
2003
|
|
| 2003
|
Dry eye in postmenopausal women enrolled in the observational study cohort of the Women's Health Initiative.
Investigative Ophthalmology and Visual Science.
44:U429-U429.
2003
|
|
| 2003
|
Is inferior tear film thinner than superior tear film?.
Investigative Ophthalmology and Visual Science.
44:U431-U431.
2003
|
|
| 2002
|
Performance and repeatability of the NEI-VFQ-25 in patients with dry eye.
Cornea.
21:578-583.
2002
|
|
| 2002
|
The performance of the contact lens dry eye questionnaire as a screening survey for contact lens-related dry eye.
Cornea.
21:469-475.
2002
|
|
| 2002
|
In vivo measurement of the thickness of human corneal endothelium and Descemet's membrane using interferometry.
Investigative Ophthalmology and Visual Science.
43:U27-U27.
2002
|
|
| 2002
|
Is there an association between signs and symptoms in patients with dry eye?.
Investigative Ophthalmology and Visual Science.
43:U1117-U1117.
2002
|
|
| 2002
|
Association of clinical diagnostic tests and dry eye surveys: The NEI-VFQ-25 and the OSDI©.
Advances in Experimental Medicine and Biology.
506 B:1177-1181.
2002
|
|
| 2002
|
Corneal staining in hydrogel lens wearers.
Optometry and Vision Science.
79:20-30.
2002
|
|
| 2002
|
Evaluation of tear film interference patterns and measures of tear break-up time.
Optometry and Vision Science.
79:363-369.
2002
|
|
| 2002
|
Patient-reported versus doctor-diagnosed dry eye: The assessment of symptoms.
Advances in Experimental Medicine and Biology.
506 B:1189-1193.
2002
|
|
| 2002
|
Results of a dry eye questionnaire from optometric practices in North America.
Advances in Experimental Medicine and Biology.
506 B:1009-1016.
2002
|
|
| 2002
|
The repeatability of diagnostic tests and surveys in dry eye.
Advances in Experimental Medicine and Biology.
506 B:1171-1175.
2002
|
|
| 2001
|
Characterization of ocular surface symptoms from optometric practices in North America.
Cornea.
20:610-618.
2001
|
|
| 2001
|
The contact lens and myopia progression (CLAMP) study: Design and baseline data.
Optometry and Vision Science.
78:223-233.
2001
|
|
| 2000
|
Frequency of dry eye diagnostic test procedures used in various modes of ophthalmic practice.
Cornea.
19:477-482.
2000
|
|
| 2000
|
Further evidence that the thickness of the normal human tear film is about 3 mu m..
Investigative Ophthalmology and Visual Science.
41:S65-S65.
2000
|
|
| 2000
|
Assessment of ocular symptoms in patient-reported dry eye versus doctor-diagnosed dry eye.
Optometry and Vision Science.
77:181.
2000
|
|
| 2000
|
Dry eye diagnostic tests and surveys: performance and association.
Optometry and Vision Science.
77:20.
2000
|
|
| 2000
|
Evaluation of the touch scientific lactoferrin microassay system: repeatability of tear lactoferrin measurements.
Optometry and Vision Science.
77:121.
2000
|
|
| 2000
|
Responses of contact lens wearers to a dry eye survey.
Optometry and Vision Science.
77:40-46.
2000
|
|
| 2000
|
The thickness of the human precorneal tear film: Evidence from reflection spectra.
Investigative Ophthalmology and Visual Science.
41:3348-3359.
2000
|
|
| 1999
|
Is the thickness of the tear film about 40 mu m or about 3 mu m?.
Investigative Ophthalmology and Visual Science.
40:S544-S544.
1999
|
|
| 1999
|
Repeatability of the NEI-VFQ in patients with dry eye syndrome.
Investigative Ophthalmology and Visual Science.
40:S910-S910.
1999
|
|
| 1999
|
Repeatability and validity of astigmatism measurements.
Journal of Refractive Surgery.
15:23-31.
1999
|
|
| 1999
|
Symptoms of ocular irritation in patients diagnosed with dry eye.
Optometry and Vision Science.
76:838-844.
1999
|
|
| 1997
|
Repeatability of astigmatism measurements.
Investigative Ophthalmology and Visual Science.
38:3965-3965.
1997
|
|
